Juan S. F.
- Country
- Spain
- Department
- N/A
Research Overview
- Evaluation of Ischemic and Bleeding Outcomes with Angiolite Stent and Abbreviated Dual Antiplatelet Therapy in Coronary Artery Disease Patients
- Efficacy of Beta-Blockers and Antiplatelet Agents in Spontaneous Coronary Artery Dissection: A Randomized Clinical Trial
- Evaluation of Beta-Blockers with Alpha Activity and Nitric Oxide Liberation in Takotsubo Syndrome: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 240 of 645 partner sites.
Specializations
Cardiac Interventions
This investigator specializes in advanced treatment approaches for patients with coronary artery disease and atrial fibrillation, particularly focusing on post-procedural care following stent implantation. Their research encompasses innovative anticoagulation strategies for patients undergoing percutaneous coronary intervention (PCI).
- Post-PCI Antithrombotic Therapy
- Coronary Stent Technologies
- Anticoagulation Management
Acute Cardiac Conditions
The investigator conducts research in treating various acute cardiac conditions, including acute coronary syndrome and spontaneous coronary artery dissection. Their work extends to studying novel therapeutic approaches for Takotsubo syndrome and acute myocardial infarction management.
- Acute Myocardial Infarction Treatment
- Emergency Cardiac Care
- Novel Therapeutic Agents
Pharmacological Interventions
Their research portfolio includes investigations into various pharmacological treatments, including beta-blockers, antiplatelet agents, and novel compounds for cardiovascular conditions. The investigator evaluates both established and experimental medications for improving patient outcomes.
- Antithrombotic Medications
- Cardiovascular Drug Development
- Treatment Optimization Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.